NFKBIA and urinary bladder cancer: Mukherjee and colleagues suggested that contextual differences in cell type confer these opposing responses: (1) methylation recruits activating cofactors that are not present in the U2OS cell line, and (2) the inhibition of IκBα by SETD6 in bladder cancer may be lost in the U2OS cell line21.